Product Code: ETC9946867 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United Kingdom Intragastric Balloons Market is experiencing growth due to an increasing prevalence of obesity and related health concerns in the region. Intragastric balloons are a non-invasive weight loss treatment option that helps individuals achieve significant weight loss by reducing stomach capacity. The market is driven by factors such as rising awareness about the benefits of weight loss procedures, technological advancements in intragastric balloon design, and a growing emphasis on preventive healthcare. Key players in the UK market include ReShape Lifesciences, Apollo Endosurgery, and Allurion Technologies. However, challenges such as high costs, limited reimbursement policies, and potential side effects may hinder market growth. Overall, the UK Intragastric Balloons Market is poised for expansion as the demand for effective weight loss solutions continues to rise.
The UK Intragastric Balloons Market is experiencing growth due to rising obesity rates and an increasing focus on non-invasive weight loss solutions. Key trends include technological advancements leading to improved balloon designs and materials, expanding awareness campaigns promoting the benefits of intragastric balloons, and a growing number of partnerships between medical device companies and healthcare providers. Opportunities in the market include the potential for reimbursement expansion, increasing adoption of intragastric balloons by healthcare professionals, and the introduction of innovative products to cater to specific patient needs. With a favorable regulatory environment and a growing demand for minimally invasive weight loss procedures, the UK Intragastric Balloons Market is poised for continued growth in the coming years.
In the United Kingdom (UK) Intragastric Balloons Market, one of the key challenges faced is limited awareness and acceptance among healthcare professionals and patients. Despite the potential benefits of intragastric balloons in aiding weight loss and managing obesity, there is still a lack of education and information dissemination about this non-invasive treatment option. Additionally, the high cost of intragastric balloon procedures and the limited coverage by insurance providers pose financial barriers for patients seeking this treatment. Moreover, there is stiff competition from other weight loss interventions such as bariatric surgery and pharmacological treatments, making it challenging for intragastric balloons to gain significant market share in the UK. Overall, increasing awareness, improving affordability, and addressing competition are crucial for the growth of the Intragastric Balloons Market in the UK.
The United Kingdom Intragastric Balloons Market is primarily driven by the increasing prevalence of obesity and related health issues in the country. As the population continues to grapple with rising obesity rates, there is a growing awareness of the need for effective weight management solutions. Intragastric balloons offer a non-surgical and minimally invasive option for weight loss, appealing to individuals who may not be suitable candidates for traditional bariatric surgery. Additionally, advancements in technology have led to the development of improved intragastric balloon systems, making them safer and more effective. The rise in disposable income and changing lifestyles also contribute to the market growth, as more individuals seek out alternatives to address their weight concerns and improve their overall health and well-being.
The UK government has regulatory policies in place for the Intragastric Balloons Market to ensure the safety and effectiveness of these devices. The Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval and monitoring of Intragastric Balloons, classifying them as medical devices subject to strict regulations. Manufacturers must comply with standards for safety, quality, and performance, as outlined in the Medical Devices Regulations. Additionally, healthcare providers offering Intragastric Balloon procedures must adhere to guidelines set by the National Institute for Health and Care Excellence (NICE) to ensure appropriate patient selection and monitoring. These policies aim to protect patient safety, promote quality healthcare delivery, and support innovation in the UK Intragastric Balloons Market.
The United Kingdom`s intragastric balloons market is expected to experience steady growth in the coming years due to a rising prevalence of obesity and an increasing awareness of non-surgical weight loss solutions. Factors such as a growing emphasis on health and wellness, technological advancements in balloon design, and an expanding obese population are likely to drive market expansion. Furthermore, the UK government`s initiatives to combat obesity and promote healthy lifestyles are anticipated to fuel market demand. With a shift towards minimally invasive procedures and a focus on improving patient outcomes, the intragastric balloons market in the UK is poised for sustained growth and innovation in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Intragastric Balloons Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Intragastric Balloons Market - Industry Life Cycle |
3.4 United Kingdom (UK) Intragastric Balloons Market - Porter's Five Forces |
3.5 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.6 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume Share, By Filling Material, 2021 & 2031F |
3.8 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United Kingdom (UK) Intragastric Balloons Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity in the UK |
4.2.2 Growing awareness about the health risks associated with obesity |
4.2.3 Technological advancements in intragastric balloon devices |
4.2.4 Rising adoption of minimally invasive weight loss procedures |
4.3 Market Restraints |
4.3.1 High cost of intragastric balloon procedures |
4.3.2 Potential side effects and complications associated with intragastric balloons |
4.3.3 Stringent regulatory requirements for medical devices in the UK |
5 United Kingdom (UK) Intragastric Balloons Market Trends |
6 United Kingdom (UK) Intragastric Balloons Market, By Types |
6.1 United Kingdom (UK) Intragastric Balloons Market, By Administration |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Administration, 2021- 2031F |
6.1.3 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Pill Form, 2021- 2031F |
6.1.4 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Endoscopy, 2021- 2031F |
6.2 United Kingdom (UK) Intragastric Balloons Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Single, 2021- 2031F |
6.2.3 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Dual, 2021- 2031F |
6.2.4 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Triple, 2021- 2031F |
6.3 United Kingdom (UK) Intragastric Balloons Market, By Filling Material |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Saline Filled, 2021- 2031F |
6.3.3 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Gas Filled, 2021- 2031F |
6.4 United Kingdom (UK) Intragastric Balloons Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United Kingdom (UK) Intragastric Balloons Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
7 United Kingdom (UK) Intragastric Balloons Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Intragastric Balloons Market Export to Major Countries |
7.2 United Kingdom (UK) Intragastric Balloons Market Imports from Major Countries |
8 United Kingdom (UK) Intragastric Balloons Market Key Performance Indicators |
8.1 Patient satisfaction rate post-intragastric balloon procedure |
8.2 Number of healthcare facilities offering intragastric balloon services |
8.3 Rate of successful weight loss outcomes post-intragastric balloon placement |
9 United Kingdom (UK) Intragastric Balloons Market - Opportunity Assessment |
9.1 United Kingdom (UK) Intragastric Balloons Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.2 United Kingdom (UK) Intragastric Balloons Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 United Kingdom (UK) Intragastric Balloons Market Opportunity Assessment, By Filling Material, 2021 & 2031F |
9.4 United Kingdom (UK) Intragastric Balloons Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United Kingdom (UK) Intragastric Balloons Market - Competitive Landscape |
10.1 United Kingdom (UK) Intragastric Balloons Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Intragastric Balloons Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |